C23H30N2O5
Neat
414.50
1309040-96-7; Ramipril hydroxydiketopiperazine; 9a-Hydroxy ramipril diketopiperazine; G1380TES6X; ethyl (2S)-2-[(2S, 6S, 8S, 11S)-8-hydroxy-11-methyl-9, 12-dioxo-1, 10-diazatricyclo[6.4.0.02, 6]dodecan-10-yl]-4-phenylbutanoate; Ramipril EP Impurity L; Ethyl (2S)-2-((3S, 5aS, 8aS, 9aS)-9a-hydroxy-3-methyl-1, 4-dioxodecahydro-2H-cyclopenta(4, 5)pyrrolo(1, 2-a)pyrazin-2-yl)-4-phenylbutanoate; 9-Hydroxy Ramipril Diketopiperazine; Ramipril impurity L [EP]; UNII-G1380TES6X; Ethyl (2S)-2-((3S, 5aS, 8aS)-9-Hydroxy-3-methyl-1, 4-dioxodecahydro-2H-cyclopenta[4, 5]pyrrolo[1, 2-a]pyrazin-2-yl)-4-phenylbutanoate; 2H-Cyclopenta(4, 5)pyrrolo(1, 2-a)pyrazine-2-acetic acid, decahydro-9a-hydroxy-3-methyl-1, 4-dioxo-alpha-(2-phenylethyl)-, ethyl ester, (alphaS, 3S, 5aS, 8aS, 9aS)-; RAMIPRIL IMPURITY L [EP IMPURITY]; Q27278517; (S)-Ethyl 2-((3S, 5aS, 8aS, 9aS)-9a-hydroxy-3-methyl-1, 4-dioxooctahydro-1H-cyclopenta[4, 5]pyrrolo[1, 2-a]pyrazin-2(5aH)-yl)-4-phenylbutanoate; (S)-Ethyl2-((3S, 5aS, 8aS, 9aS)-9a-hydroxy-3-methyl-1, 4-dioxooctahydro-1H-cyclopenta[4, 5]pyrrolo[1, 2-a]pyrazin-2(5aH)-yl)-4-phenylbutanoate; 2H-CYCLOPENTA(4, 5)PYRROLO(1, 2-A)PYRAZINE-2-ACETIC ACID, DECAHYDRO-9A-HYDROXY-3-METHYL-1, 4-DIOXO-.ALPHA.-(2-PHENYLETHYL)-, ETHYL ESTER, (.ALPHA.S, 3S, 5AS, 8AS, 9AS)-; Ethyl (2S)-2-[(3S, 5aS, 8aS, 9aS)-9a-hydroxy-3-methyl-1, 4-dioxodecahydro-2H-cyclopenta[4, 5]pyrrolo [1 and 2-a]pyrazin-2-yl]-4-phenylbutanoate
ethyl (2S)-2-[(2S, 6S, 8S, 11S)-8-hydroxy-11-methyl-9, 12-dioxo-1, 10-diazatricyclo[6.4.0.02 and 6]dodecan-10-yl]-4-phenylbutanoate
InChI=1S/C23H30N2O5/c1-3-30-21(27)19(13-12-16-8-5-4-6-9-16)24-15(2)20(26)25-18-11-7-10-17(18)14-23(25,29)22(24)28/h4-6,8-9,15,17-19,29H,3,7,10-14H2,1-2H3/t15-,17-,18-,19-,23-/m0/s1